• 1
    Nardin, E. H. and Nussenzweig, R. S., T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 1993. 11: 686727.
  • 2
    Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J. and Greenwood, B. M., Common West African HLA antigens are associated with protection from severe malaria. Nature 1991. 352: 595600.
  • 3
    Plebanski, M., Aidoo, M., Whittle, H. C. and Hill, A. V. S., Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 1997. 158: 28492855.
  • 4
    Aidoo, M., Lalvani, A., Allsopp, C. E. M., Plebanski, M., Meisner, S. J., Krausa, P., Browning, M., Morris Jones, S., Gotch, F., Fidock, D. A., Takiguchi, M., Robson, K. J. H., Greenwood, B. M., Druilhe, P., Whittle, H. C. and Hill, A. V. S., Identification of conserved antigenie components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995. 345: 10031007.
  • 5
    Lockyer, M. J., Marsh, K. and Newbold, C. I., Wild isolates of Plasmodium falciparum show extensive polymorphism in Tcell epitopes of the circumsporozoite protein. Molecular And Bioch. Parasitol. 1989. 37: 275280.
  • 6
    Qari, S. H., Collins, W. E., Lobel, H. O., Taylor, F. and Lai, A. A., A study of polymorphism in the circumsporozoite protein of human malaria parasites. Am. J. of Trop. Med. Hyg. 1994. 50: 4551.
  • 7
    Stoute, J. A., Slaoui, M., Heppner, G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garcon, N., Krzych, U., Marchand, M., Ballou, R. and Cohen, J., A preliminary evaluation of a recombinant Circumsporozite Protein vaccine again Plasmodium Falciparum Malaria. The New England J. Med. 1997. 336: 8691.
  • 8
    Thomson, S. A., Khanna, R., Gardner, J., Burrows, S. R., Coupar, B., Moss, D. J. and Suhrbier, A., Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc. Natl. Acad. Sci. USA 1995. 92: 58455849.
  • 9
    Whitton, J. L., Sheng, N., Oldstone, M. B. and McKee, T. A., A “string-of-beads” vaccine, comprising linked minigenes, confers protection froom lethal-dose virus challenge. J. Virol. 1993. 67: 348352.
  • 10
    Adams, S. E., Dawson, K. M., Gull, K., Kingsman, S. M. and Kingsman, A. J., The expression of hybrid HIV: Ty virus-like particles in yeast. Nature 1987. 329: 6870.
  • 11
    Layton, G. T., Harris, S. J., Gearing, A. J., Hill Perkins, M., Cole, J. S., Griffiths, J. C., Burns, N. R., Kingsman, A. J. and Adams, S. E., Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3: Ty-virus-like particles. J. Immunol. 1993. 151: 10971107.
  • 12
    Layton, G. T., Harris, S. J., Myhan, J., West, D., Gotch, F., Hill Perkins, M., Cole, J. S., Meyers, N., Woodrow, S., French, T. J., Adams, S. E. and Kingsman, A. J., Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles. Immunology 1996. 87: 171178.
  • 13
    Sutter, G. W., Wyatt, L. S., Foley, P. L., Bennink, J. R. and Moss, B., A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 1994. 12: 10321040.
  • 14
    Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V. and Zavala, F., Cloned cytotoxic Tcells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989. 341: 323326.
  • 15
    Weber, J., Cheinsong Popov, R., Callow, D., Adams, S., Patou, G., Hodgkin, K., Martin, S., Gotch, F. and Kingsman, A., Immunogenicity of the yeast recombinant p17/p24: Ty virus-like particles (p24-VLP) in healthy volunteers. Vaccine 1995. 13: 831834.
  • 16
    Martin, S. J., Vyakarnam, A., Cheingsong Popov, R., Callow, D., Jones, K. J., Senior, J. M., Adams, S. E., Kingsman, A. J., Matear, P., Gotch, F. M. and et al., Immunization of human HIV-seronegative volunteers with recombinant p17/p24: Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses AIDS 1993. 7: 13151323.
  • 17
    Blanchard, T. J., Rowland-Jones, S., Gotch, F., McMichael, A. J. and Smith, G. L., Future vaccines for HIV. Lancet 1997. 348: 1741.
  • 18
    Mayr, A., Stick), H., Muller, H. K., Danner, K. and Singer, H., [The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behaviour in organism with a debilitated defence mechanism (author's translation)]. Der Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrungen mit der parenteralen Schutzimp-fung und Verhalten im abwehrgeschwächten Organismus. Zentralbl. Bakteriol. B. 1978. 167: 375390.
  • 19
    Allsopp, C. E. M., Plebanski, M., Gilbert, S., Sinden, R. E., Harris, S., Frankel, G., Dougan, G., Hioe, C., Nixon, D., Paoletti, E., Layton, G. and Hill, A. V. S., Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 1996. 26: 19511959.
  • 20
    Panina Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A., Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by Tcells. Eur. J. Immunol. 1989. 19: 22372242.
  • 21
    Munesinghe, D. Y., Clavijo, P., Calle, M. C., Nussenzweig, R. S. and Nardin, E., Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. Eur. J. Immunol. 1991. 21: 30153020.
  • 22
    Brown, A. E., Chandanayingyong, D., Fuggle, S. V. and Webster, H. K., Immune responses to the circum-sporozoite protein of Plasmodium falciparum in relation to HLA-DR type. Tissue Antigens 1989. 34: 200204.
  • 23
    Ballou, W. R., Rothbard, J., Wirtz, R. A., Gordon, D. M., Williams, J. S., Gore, R. W., Schneider, I., Hollingdale, M. R., Beaudoin, R. L., Maloy, W. L., Miller, L. H. and Hockmeyer, W. T., Immunogenicity of synthetic peptides from the circumsporozite protein of Plasmodium falciparum. Science 1985. 228: 996999.
  • 24
    Bertoletti, A., Costanzo, A., Chisari, F. V., Levrero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F. and Ferrari, C., Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 1994. 180: 933943.
  • 25
    Mueller, H. M., Reckmann, I., Hollingdale, M. R., Bujard, H., Robson, K. J. H. and Crisanti, A., Throm-bospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glyco-conjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J. 1993. 12: 28812889.
  • 26
    Robson, K. J. H., Frevert, U., Reckmann, I., Cowan, G., Beier, J., Scragg, I. G., Takehara, K., Bishop, D. H. L., Pradel, G., Sinden, R., Saccheo, S., Mueller, H. M. and Crisanti, A., Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: Expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J. 1995. 14: 38833894.
  • 27
    Jager, E., Ringhoffer, M., Dienes, H. P., Arand, M., Karbach, J., Jager, D., Llsemann, C., Hagedorn, M., Oesch, F. and Knuth, A., Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer 1996. 67: 5462.
  • 28
    Doolan, D. L., Sedegah, M., Hedstrom, R. C., Hobart, P., Charoenvit, Y. and Hoffman, S. L., Circumventing genetic restriction of protection against Malaria with Multigene DNA Immunization: CD8+ T cell-, Interferon γ-, and Nitric Oxide-dependant immunity. J. Exp. Med. 1996. 183: 17391746.
  • 29
    Renggli, J., Valmori, D., Romero, J. F., Eberl, G., Romero, P., Betschart, B. and Corradin, G., CD8+ protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria. Immunol. Lett. 1995. 46: 199205.
  • 30
    Renggli, J., Hahne, M., Matile, H., Beetschart, B., Tschopp, J. and Corradin, G., Elimation of P. berghei liver stages is independent of Fas (CD95/Apo-I or perforin-mediated cytotoxicity. Parasite Immunol. 1997. 19: 145148.
  • 31
    Hoffman, S. L., Isenbarger, D., Long, G. W., Sedegah, M., Szarfman, A., Waters, L., Hollingdale, M. R., Van der Meide, P. H., Finbloom, D. S. and Ballou, W. R., Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 1989. 244: 10781081.
  • 32
    Mellouk, S., Green, S. J., Nacy, C. A. and Hoffman, S. L., IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 1991. 146: 39713976.
  • 33
    Rodrigues, M., Shengqiang, L., Murata, K., Rodriguez, D., Rodriguez, J. R., Bacik, I., Bennink, J. R., Yewdell, J. W., Garcia-Sastre, A., Nussenzweig, R. S., Esteban, M., Palese, P. and Zavala, F., Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J. Immunol. 1994. 153: 46364648.
  • 34
    Li, S., Rodrigues, M., Rodriguez, D., Rodriguez, J. R., Esteban, M., Palese, P., Nussenzweig, R. S. and Zavala, F., Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T cell mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 1993. 90: 52145218.
  • 35
    Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Backer, M., Sinden, R., Smith, G. L. and Hill, A. V. S., Enhanced immunogenicity for CTL induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med. 1998. 4: 397402.
  • 36
    Alcamf, A. and Smith, G. L., A mechanism for inhibition of fever by a virus. Proc. Natl. Acad. Sci. USA 1996. 93: 1102911034.
  • 37
    Plebanski, M., Elson, C. J. and Billington, W. D., Dependency on interleukin-1 of primary human in vitro Tcell responses to soluble antigens. Eur. J. Immunol. 1992. 22: 23532358.
  • 38
    Plebanski, M., Allsopp, C. E. M., Aidoo, M., Reyburn, H. and Hill, A. V. S., Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. Eur. J. Immunol. 1995. 25: 17831787.
  • 39
    Vordermeier, H. M., Harris, D. P., Friscia, G., Roman, E., Surcel, H. M., Moreno, C., Pasvol, G. and Ivanyi, J., Tcell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur. J. Immunol. 1992. 22: 26312637.
  • 40
    Gilbert, S. C., Plebanski, M., Harris, S. J., Allsopp, C. E. M., Thomas, R., Layton, G. T. and Hill, A. V. S. Nature Biotech. 1997. 15: 12801284.
  • 41
    Hedstrom, R. C., Sedegah, M. and Hoffman, S. L., Prospects and strategies for development of DNA vaccines against malaria. Res. Immun. 1994. 145: 476483.
  • 42
    Mor, G., Singla, M., Steinberg, A., Hoffman, S., Okuda, K. and Klinman, D., Do DNA vaccines induce autoimmune disease?. Human Gene Therapy 1997. 8: 293300.
  • 43
    Chakrabarti, S., Brechling, K. and Moss, B., Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 1985. 5: 34033409.
  • 44
    Carroll, M. W. and Moss, B., E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. Biotechniques 1995. 19: 352354, 356.
  • 45
    Miyahira, Y., Murata, K., Rodriguez, D., Esteban, M., Rodrigues, M. M. and Zavala, F., Quantification of antigen specific CD8+ Tcells using an ELISPOT assay. J. Immunol. Methods 1995. 181: 4554.